Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000713525 | SCV000844147 | pathogenic | not provided | 2018-07-24 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000713525 | SCV001501457 | pathogenic | not provided | 2020-10-01 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000009561 | SCV002021969 | pathogenic | Congenital lipoid adrenal hyperplasia due to STAR deficency | 2020-09-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000713525 | SCV002233140 | pathogenic | not provided | 2023-07-31 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 586680). This sequence change creates a premature translational stop signal (p.Tyr68Glnfs*2) in the STAR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in STAR are known to be pathogenic (PMID: 8948562). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with congenital lipoid adrenal hyperplasia (PMID: 17666473, 18058976). |
Fulgent Genetics, |
RCV000009561 | SCV002816130 | pathogenic | Congenital lipoid adrenal hyperplasia due to STAR deficency | 2024-02-18 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000009561 | SCV000029779 | pathogenic | Congenital lipoid adrenal hyperplasia due to STAR deficency | 2007-10-01 | no assertion criteria provided | literature only | |
Natera, |
RCV000009561 | SCV002083266 | pathogenic | Congenital lipoid adrenal hyperplasia due to STAR deficency | 2020-12-08 | no assertion criteria provided | clinical testing |